Clinical trials: The rise of IL-2 therapy - a novel biologic treatment for SLE
- PMID: 27761021
- DOI: 10.1038/nrrheum.2016.173
Clinical trials: The rise of IL-2 therapy - a novel biologic treatment for SLE
Comment on
-
Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus.Nat Med. 2016 Sep;22(9):991-3. doi: 10.1038/nm.4148. Epub 2016 Aug 8. Nat Med. 2016. PMID: 27500725
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
